Aug312016Prostate Cancer Survival was longer in patients who received radium-223 plus abiraterone, enzalutamide, or both. Read the source article at Renal & Urology News Category: Prostate CancerAugust 31, 2016 Share this post Share on FacebookShare on Facebook TweetShare on Twitter Pin itShare on Pinterest Share on LinkedInShare on LinkedIn Post navigationPreviousPrevious post:Skeletal-Related Events Predict Higher Mortality in mCRPCNextNext post:High-Risk PCa Found in Black Men Initially on Active SurveillanceRelated postsRacial Disparities Found in Prostate Cancer TreatmentOctober 9, 2016New Nuclear-Imaging Tests Show Promise in Locating CancerOctober 9, 2016Cancer-Detecting Dogs? They’re Being Trained in Costa RicaOctober 8, 2016Online Programs Help to Address Effects of Prostate Cancer TreatmentOctober 7, 2016Bacteremia Often Caused by TURPOctober 7, 2016Effects of Testosterone-Lowering Drugs in Patients With Prostate CancerOctober 6, 2016